The Hyderabad based Covid-19 vaccine Covaxin has moved yet another step closer to a World Health Organisation (WHO) approval, with the global health body starting on Tuesday that the pre-submission meeting held on June 23 with Bharat Biotech, the rolling data will be starting in July.
WHO had accepted Bharat Biotech’s expression of interest (EoI) for the inactivated vaccine in mid-June after the Hyderabad-based vaccine maker provided the additional data that it had sought.
A senior Bharat Biotech official had told TOI that Covaxin’s dossier would be complete and taken up for review by WHO only after the company submits the entire Phase-3 clinical trials data in july.
The status of Covid-19 vaccines within the EUL/PQ(emergency use listing/prequalification) evaluation process was updated on Tuesday by WHO in its latest guidance document.
Discussion about this post